[Clinical evaluation of the preparation Donalgin in the treatment of rheumatoid arthritis and ankylosing spondylitis].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use* / Q000633:toxicity; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009544:Niflumic Acid / Q000627:therapeutic use* / Q000633:toxicity; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D009544:Niflumic Acid
Ocena kliniczna preparatu donalgin w leczeniu reumatoidalnego zapalenia stawów i zesztywniajacego zapalenia stawów kregosłupa.